A detailed history of Grant transactions in Johnson & Johnson stock. As of the latest transaction made, Grant holds 6,868 shares of JNJ stock, worth $1.13 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
6,868
Previous 6,863 0.07%
Holding current value
$1.13 Million
Previous $1.09 Million 7.56%
% of portfolio
0.52%
Previous 0.57%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$144.38 - $157.78 $721 - $788
5 Added 0.07%
6,868 $1 Million
Q1 2024

Apr 25, 2024

SELL
$155.22 - $162.74 $445,481 - $467,063
-2,870 Reduced 29.49%
6,863 $1.09 Million
Q4 2023

Jan 30, 2024

SELL
$145.6 - $158.88 $50,086 - $54,654
-344 Reduced 3.41%
9,733 $1.53 Million
Q3 2023

Oct 24, 2023

SELL
$155.75 - $174.48 $219,607 - $246,016
-1,410 Reduced 12.27%
10,077 $1.57 Million
Q2 2023

Jul 19, 2023

BUY
$154.35 - $166.11 $19,293 - $20,763
125 Added 1.1%
11,487 $1.9 Million
Q1 2023

May 01, 2023

BUY
$151.05 - $180.26 $1,963 - $2,343
13 Added 0.11%
11,362 $1.76 Million
Q4 2022

Jan 10, 2023

SELL
$160.2 - $179.79 $4,165 - $4,674
-26 Reduced 0.23%
11,349 $0
Q3 2022

Nov 02, 2022

BUY
$161.33 - $179.52 $293,136 - $326,187
1,817 Added 19.01%
11,375 $1.94 Million
Q2 2022

Jul 20, 2022

BUY
$168.19 - $186.01 $168 - $186
1 Added 0.01%
9,558 $1.68 Million
Q1 2022

Apr 25, 2022

BUY
$158.14 - $179.59 $455,443 - $517,219
2,880 Added 43.13%
9,557 $1.75 Million
Q4 2021

Jan 13, 2022

SELL
$155.93 - $173.01 $11,382 - $12,629
-73 Reduced 1.08%
6,677 $1.14 Million
Q3 2021

Oct 27, 2021

BUY
$161.5 - $179.47 $37,952 - $42,175
235 Added 3.61%
6,750 $1.11 Million
Q2 2021

Aug 05, 2021

BUY
$159.48 - $171.07 $318 - $342
2 Added 0.03%
6,515 $1.1 Million
Q1 2021

May 04, 2021

SELL
$153.07 - $170.48 $5,357 - $5,966
-35 Reduced 0.53%
6,513 $1.06 Million
Q4 2020

Jan 15, 2021

BUY
$137.11 - $157.38 $897,796 - $1.03 Million
6,548 New
6,548 $1.03 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $430B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Grant Portfolio

Follow Grant and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grant, based on Form 13F filings with the SEC.

News

Stay updated on Grant with notifications on news.